154 related articles for article (PubMed ID: 20708786)
1. Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.
Lim EH; Ng SL; Li JL; Chang AR; Ng J; Ilancheran A; Low J; Quek SC; Tay EH
Gynecol Oncol; 2010 Nov; 119(2):225-31. PubMed ID: 20708786
[TBL] [Abstract][Full Text] [Related]
2. Methylation in the promoters of HS3ST2 and CCNA1 genes is associated with cervical cancer in Uygur women in Xinjiang.
Zuo Q; Zheng W; Zhang J; Pan Z; Liu Y; Long H; Fan P; Guo C; Li F; Shao R
Int J Biol Markers; 2014 Dec; 29(4):e354-62. PubMed ID: 25198553
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
Fan C; Hu J; Luo T; Dong B; Li H; Wang W; Yan J; Cai H
J Med Virol; 2024 May; 96(5):e29521. PubMed ID: 38727013
[TBL] [Abstract][Full Text] [Related]
4. CCNA1 promoter methylation: a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesions.
Chujan S; Kitkumthorn N; Siriangkul S; Mutirangura A
Asian Pac J Cancer Prev; 2014; 15(18):7971-5. PubMed ID: 25292097
[TBL] [Abstract][Full Text] [Related]
5. [Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application].
Zhong ZJ; Yang JX; Cao DY; Sun Y; Sun LL; Cheng XM; Chen J; Lang JH; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):196-200. PubMed ID: 22781071
[TBL] [Abstract][Full Text] [Related]
6. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
7. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.
Sun Y; Li S; Shen K; Ye S; Cao D; Yang J
Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825
[TBL] [Abstract][Full Text] [Related]
8. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
Gynecol Oncol; 2010 Jan; 116(1):99-104. PubMed ID: 19836067
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis.
Gustafson KS; Furth EE; Heitjan DF; Fansler ZB; Clark DP
Cancer; 2004 Aug; 102(4):259-68. PubMed ID: 15368319
[TBL] [Abstract][Full Text] [Related]
10. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests.
Kahn SL; Ronnett BM; Gravitt PE; Gustafson KS
Cancer; 2008 Feb; 114(1):57-64. PubMed ID: 18181097
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Kweon SS; Fackler MJ; Sukumar S
Virchows Arch; 2010 Jul; 457(1):35-42. PubMed ID: 20496080
[TBL] [Abstract][Full Text] [Related]
13. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.
Xu J; Xu L; Yang B; Wang L; Lin X; Tu H
Int J Clin Exp Pathol; 2015; 8(2):1674-81. PubMed ID: 25973053
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel DNA methylation markers in cervical cancer.
Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of candidate methylation markers to detect cervical neoplasia.
Shivapurkar N; Sherman ME; Stastny V; Echebiri C; Rader JS; Nayar R; Bonfiglio TA; Gazdar AF; Wang SS
Gynecol Oncol; 2007 Dec; 107(3):549-53. PubMed ID: 17894941
[TBL] [Abstract][Full Text] [Related]
16. Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
Chang CC; Huang RL; Liao YP; Su PH; Hsu YW; Wang HC; Tien CY; Yu MH; Lin YW; Lai HC
BMC Cancer; 2015 May; 15():418. PubMed ID: 25985991
[TBL] [Abstract][Full Text] [Related]
17. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
18. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.
Flatley JE; McNeir K; Balasubramani L; Tidy J; Stuart EL; Young TA; Powers HJ
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2782-9. PubMed ID: 19755648
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
20. [A multicenter study on the accuracy of PAX1/JAM3 dual genes methylation testing for screening cervical cancer].
Shang X; Kong LH; Xiao XP; Wan R; Wang J; Wu HW; Chen XY; Shou HF; Fei J; Zhou JW; Lang JH; Li L
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1852-1859. PubMed ID: 38782754
[No Abstract] [Full Text] [Related]
[Next] [New Search]